Esophageal cancer marker
A technology of esophageal cancer and composition, applied in the field of esophageal cancer markers, can solve the problems of not finding esophageal cancer-specific, early-stage esophageal cancer, and difficult-to-carcinoma-specific transporters
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
preparation example Construction
[0110] The preparation of polyclonal antibodies can be carried out according to the following steps. First, an antigen (for example, the full length or a part of the SLC38A4 protein described in SEQ ID NO: 1) is prepared, and then animals such as rabbits are immunized with the antigen. The SLC38A4 protein as an antigen can be prepared by separating and purifying it from a biological sample. In addition, SLC38A4 protein prepared as a recombinant protein can also be used as an antigen. The recombinant protein is prepared by inserting the gene encoding the SLC38A4 protein or a part thereof into a vector in an expressible state, introducing the vector into an appropriate host, and then isolating and purifying the protein expressed in the host. The SLC38A4 protein, preferably the peptide region comprising the 29th to 47th amino acid sequence "GIGNSEKAAMSSQFANEDT" (SEQ ID NO. 2) can be prepared to combine with GST, β-galactosidase, maltose binding protein, histidine ( A fusion pro...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com